INTRODUCTION
Matrix metalloproteinases (MMPs) are a family of zinc endopeptidases that play critical roles in extracellular matrix remodelling in development and disease [1, 2] . Two recent geneablation studies have shown that angiogenesis is mediated by membrane-type MMP 1 (MT1-MMP) and MMP-2 [3, 4] , leading to the development of tissue inhibitor of metalloproteinase (TIMP)-based strategies such as anti-cancer gene therapeutics (reviewed in [5] ). Four TIMPs have now been cloned, each representing proteins of around 190 amino acid residues [6] [7] [8] [9] The inhibitory features of TIMP-1, -2 and -3 have been well characterized and they inhibit most members of the MMP family with low inhibition constants (reviewed in [10] ). However, they show variations in their affinity for different MMPs due to differences in their ability to interact with the catalytic domain, e.g. MT1-MMP, MT2-MMP and MT5-MMP are only poorly inhibited by TIMP-1 [11] . 192 -Q 193 from TIMP-4; proE 375 → A MMP-2-TIMP-2, bimolecular complex between proE 375 → A MMP-2 and TIMP-2; SL, stromelysin-1; proMMP-2-C-SL, proMMP-2 mutant encoding the C-terminal domain of SL residues 248-460; proMMP-2-C-SLGLGL, proMMP-2 mutant encoding C-terminal domain residues 248-305 from SL and residues 475-631 from MMP-2; proMMP-2-C-SLGLSL, proMMP-2 mutant encoding C-terminal domain residues 248-305 and 400-460 from SL and residues 475-567 from MMP-2. 1 These authors contributed equally to this work. 2 Present address: University of Cambridge, Department of Oncology, Cambridge Institute for Medical Research, Hills Road, Cambridge CB2 2XY, U.K. 3 To whom correspondence should be addressed (e-mail vk8@york.ac.uk and gm290@cam.ac.uk).
TIMP-4 is the most recent member of the TIMP family and two initial studies have provided some insight into its specificity for individual MMPs [12, 13] . It has been shown that TIMP-4 binds to progelatinase A (proMMP-2) via the C-terminal domain of the enzyme [13, 14] . However, unlike TIMP-2, TIMP-4 is unable to promote proMMP-2 activation by MT1-MMP [14] [15] [16] . ProMMP-2 activation is thought to be dependent on the establishment of an 'MT1-MMP/TIMP-2' receptor, which mediates proMMP-2 binding through C-terminal-domain interactions, forming a trimolecular complex at the cell surface. An adjacent inhibitorfree MT1-MMP molecule is involved in stepwise proteolytic processing of proMMP-2 to an intermediate form, which then undergoes auto proteolysis, generating the fully active enzyme which is released from the cell membrane [17] [18] [19] [20] . TIMP-2 −/− mice were shown to be deficient in proMMP-2 activation by MT1-MMP in vivo [21, 22] , suggesting that TIMP-2 is unique amongst the TIMPs in promoting proMMP-2 activation at low inhibitor concentrations.
Table 1 Summary of oligonucleotides used to create mouse TIMP-4 mutants
Mutations are described in the text. Underlined residues: primer 1, NdeI site; primer 2, stop codon and EcoRI site.
Mutation
Oligonucleotide We have demonstrated previously that the C-terminal domain of TIMP-2 is required for efficient interaction with both pro-and active MMP-2 [23] . In contrast, the C-terminal domain of TIMP-2 showed no significant interaction with MT1-MMP. However, we were able to define a highly specific N-terminal-domain interaction involving the residue Tyr 36 . Substitution of this residue with glycine resulted in a 40-fold increase of the K app i for MT1-MMP, but had no effect on the TIMP-2/MMP-2 rate of binding. It might be speculated that their respective N-terminal domains mainly govern the MT1-MMP-TIMP-2 interactions, while their C-terminal domains rule the proMMP-2-TIMP-2 interactions. In view of these specialized interactions between the members of the trimolecular complex, TIMP-2, proMMP-2 and MT1-MMP, we set out to determine the sequence requirements for TIMP-2-dependent proMMP-2 activation by MT1-MMP at the molecular level.
This was achieved by analyses of site-directed mutants derived from murine TIMP-4 and human TIMP-2 in solution and using a cellular model system established from TIMP-2 −/− cells. We report gain and loss of function of murine TIMP-4 or human TIMP-2 mutants, and identify residues that are important for trimolecular complex formation and proMMP-2 activation. The implications of our findings are discussed in the light of the recently published X-ray crystal structure analysis of the proMMP-2-TIMP-2 complex [24] . Our data represent the basis of future work to engineer TIMP-2 mutants that are capable of preventing proMMP-2 activation by MT1-MMP at the cell surface.
EXPERIMENTAL Preparation of murine TIMP-4 and human TIMP-2 mutants
An Escherichia coli expression vector for the N-terminus of TIMP-4 with residues 129-195 deleted (N-TIMP-4) was generated by PCR using the mutagenic oligonucleotides 1 and 2 (Table 1) , thereby introducing an NdeI site preceding Cys 1 and a stop codon following Gly 128 , flanked by a unique EcoRI site. The PCR product was ligated into pRSET A. Ligating the XcmI to EcoRI C-terminal domain fragment into N-TIMP-4 pRSET A generated a full-length TIMP-4 expression vector. The TIMP mutants used in this study are shown schematically in Figure 1 (top panel), and were created using the oligonucleotides summarized in Table 1 by the following procedures. The TIMP-4:TIMP-2 tail mutants were generated by cleaving the full-length TIMP-4 pRSET A construct with PstI and HindIII, followed by the ligation of annealed oligonucleotides (Table 1 , oligonucleotide nos. 6-11).
The N-TIMP-4:C-TIMP-2 (TIMP-4 residues 1-128:TIMP-2 residues 128-194) chimaeric TIMP expression vector was generated by PCR using coding mutagenic primer no. 5 (Table 1) and a non-coding vector primer and the human TIMP-2 cDNA in pET23d as the template. The PCR product was subcloned into the XcmI-and EcoRI-cleaved N-TIMP-4 pRSET A construct. A chimaeric TIMP N-TIMP-2:C-TIMP-4 (TIMP-2 residues 1-127:TIMP-4 residues 129-195) was constructed by PCR overlapextension mutagenesis using vector and mutagenic primers 3 and 4. The resulting PCR product was cleaved with BamHI and EcoRI and ligated into the N-TIMP-2 (N-terminus of TIMP-2 with residues 128-194 deleted) pET23d expression vector cleaved with these restriction enzymes. An IQ-TIMP-2 mutant (TIMP-2 with tail-sequence residues I 192 -Q 193 from TIMP-4) was generated by PCR, thereby replacing the E 192 -D 193 sequence motif of TIMP-2 with the corresponding residues in TIMP-4 using reverse mutagenic primer no. 12 (Table 1 ) and a coding primer upstream of the internal BamHI site within the human TIMP-2 cDNA. The resulting PCR product was cleaved with BamHI and HindIII and ligated into the N-TIMP-2 pET23d expression vector cleaved with these restriction enzymes.
All resulting vectors were sequenced using the dideoxy method. With the exception of N-TIMP-2:C-TIMP-4 all mutants showed the desired cDNA sequence. The N-TIMP-2:C-TIMP-4 had an additional mutation converting Lys 116 into Arg. Lys 116 does not interact with the target enzyme, as revealed by the X-ray structures of the MT1-MMP-TIMP-2 complex, thus allowing us to use the inhibitor in this study. E. coli BL21(DE3)pLysS were used to produce the seven TIMP-4 mutants. Subsequently, proteins were refolded as described for N-TIMP-2 and purified using SPSepharose [25] .
Analysis of the structural integrity of the refolded inhibitors
The refolding of N-TIMP-4, full-length TIMP-4 and all TIMP-4 mutants was optimized using the refolding method developed previously for N-TIMP-2 [26] . The molecular masses determined under reducing conditions were 16 000 Da for N-TIMP-4 and 27 000 Da for full-length wild-type and mutant TIMP-4, while under non-reducing conditions they were found to be 14 500 and 23 000 Da (results not shown). The unfolding transition of N-TIMP-4 was highly co-operative, showing a sharp transition curve with a midpoint of denaturation at 2.35 M guanidinium chloride, a value very similar to that of N-TIMP-2 [27] . The unfolding of native TIMP-2 and refolded chimaeric or TIMP-4 tail mutants showed co-operativity with parallel shallower transition curves at lower guanidinium chloride concentrations [27] . The curves observed for the different TIMP-4 mutants showed only minor differences, indicating structural integrity and correct folding. The structural integrity of the TIMP-4 mutants was upheld by their ability to inhibit active catMT1-MMP (haemopexin domain deletion mutant of MT1-MMP with residues 269-559 deleted) and by bimolecular complex formation with proMMP-2 as shown in the Results section indicating that both the N-and C-terminal domains were correctly folded and fully functional.
Generation of TIMP-2, TIMP-4 and TIMP mutant mammalian expression vectors
Wild-type TIMP-2 in pEE12 was described previously [24] . I 192 -Q 193 TIMP-2 was prepared using the human TIMP-2 cDNA in pSP65 in conjunction with a reverse mutagenic primer (Table 1 , oligonucleotide no. 12) encoding the IQ-TIMP-2 and a forward primer complementary to the signal sequence, which introduced a 5 EcoRI site. The resulting PCR product was cleaved with EcoRI and HindIII and ligated into pcDNA3.1 (−). The BamHI-HindIII TIMP-4 cDNA fragment was cloned into BamHI-and HindIIIcleaved pcDNA3.1 (−). The N-TIMP-4:C-TIMP-2 pcDNA3.1 vector was prepared by excision of the XcmI-HindIII TIMP-4 C-domain fragment and subsequent ligation of the XcmIHindIII TIMP-2 C-domain fragment from the N-TIMP-4:C-TIMP-2 pRSET A vector described above. Expression was analysed following transient transfection into COS 7 cells and confirmed that the vectors were fully functional (results not shown).
Characterization of a polyclonal antibody against N-TIMP-4
HPLC purified N-TIMP-4 was used to produce a polyclonal antiserum in sheep [28] . The antibody was affinity purified using TIMP-4 and shown to react specifically with N-TIMP-4, TIMP-4 and N-TIMP-4:C-TIMP-2 by Western blotting, but it did not cross-react with other TIMPs (results not shown).
Recombinant MMPs
Recombinant wild-type and mutant proMMP-2 were produced using stably transfected mouse myeloma cells and purified from the cell-conditioned medium ( Figure 2 , top panel) [29, 30] . A soluble form of MT1-MMP comprised of the propeptide and the catalytic domain, pro-catMT1-MMP, was expressed in BL21(DE3)pLysS using a pRSET B construct, refolded from inclusion bodies and purifed by Ni 2+ -nitrilotriacetate-agarose chromatography. The purified refolded protein was dialysed to remove imidazole, which resulted in partial spontaneous activation. Full activation was achieved by incubation for 15 min at 37
• C, which resulted in spontaneous conversion to the fully processed form of the enzyme [25, 31] .
Bimolecular complexes between proMMP-2 mutants and TIMP-4 mutants
Wild proMMP-2, C-terminal-deleted pro 418−631 MMP-2 and Cterminal domain stromelysin-1 (SL) chimaeras of proMMP-2 ( Figure 2 , top panel) [32] were incubated with 2-fold molar excess of either wild-type or mutant TIMP-4 for 24 h in order to allow complex formation. The complexes were isolated using gelatinSepharose. Bimolecular complexes between proE 375 → A MMP-2 and mutant TIMPs were incubated with a 2-fold molar excess of active catMT1-MMP to allow trimolecular complex formation. Similar Top panel: the MMP-2 C-terminal haemopexin domain was replaced by portions of SL Cterminal domain as detailed in [29] . SL domains are represented in grey and the corresponding amino acid residues of SL are indicated. The bordering amino acid residues from MMP-2 (GL) are indicated on the left of the diagram. Mutants are described in the text. Bottom panel: the MMP-2 and MMP-3 C-terminal domain chimaeric proteins described in the top panel were incubated with TIMP-4 and the complexes isolated by gelatin-affinity chromatography. The formation of bimolecular complexes was established by the presence of TIMP-4 in the matrix eluates prepared as described in the Experimental section and analysed by SDS/PAGE. Lane 1, proMMP-2-C-SL; lane 2, proMMP-2-C-SLGLSL; lane 3, proMMP-2-C-SLGLGL; lane 4, wild-type proMMP-2. The protein band corresponding to TIMP-4 is indicated on the right. The gel was processed under reducing conditions. experiments were performed with a bimolecular complex between proE 375 → A MMP-2 and TIMP-2 (proE 375 → A MMP-2-TIMP-2) as a positive control for trimolecular complex formation. The respective trimolecular complexes were isolated using gelatinSepharose chromatography.
Kinetic analysis of enzyme inhibitor interactions
The concentrations of the active enzymes were estimated by titration against TIMP-1 or TIMP-2 of known concentration, as appropriate [33] . The concentration of TIMP-4 and N-TIMP-4 were determined using MMP-13 of known concentration. The kinetics for the inhibition of active catMT1-MMP and active MMP-2 with wild-type and N-TIMP-4 were analysed by evaluation of the second-order rate constant k on [23] . The apparent K app i values for inhibition of catMT1-MMP were determined following a 24 h preincubation period at 25
• C to establish equilibrium [25] . The apparent K app i values for inhibition of MMP-2 could not be determined due to their low values [34] . All reactions were performed with McaPLGLDpaARNH 2 [7- 
as the substrate at 25
• C using a PerkinElmer spectrofluorimeter (LS 50B) [35] .
SDS/PAGE and Western Blotting
Samples to be analysed by SDS/PAGE were diluted 1:1 with SDS sample buffer (100 mM Tris/HCl, pH 6.8/10 % SDS/ 10 % glycerol with or without 1 % β-mercaptoethanol) and boiled for 5 min prior to SDS/PAGE using 12 % or 10 % acrylamide separation gels and staining with Coomassie Brilliant Blue. Western blots were developed using polyclonal antibodies to MT1-MMP [32] , 4 cells were seeded on to 12-well plates and serum-free medium supplemented with increasing amounts of either wild-type TIMP-4 or TIMP-2 and 100 ng/ml recombinant proMMP-2. After 24 or 48 h the cellconditioned medium and lysates were analysed for the presence of active MMP-2. Processing of MT1-MMP was analysed by Western blot analysis using a polyclonal antibody to MT1-MMP [32] .
MT1-MMP-containing membranes

TIMP-2
−/− mouse fibroblasts transfected with MT1-MMP were grown in the presence of 1 µM of the MMP inhibitor BB94, to stabilize cell-surface MT1-MMP. When 80 % confluent, the cells were washed three times with Dulbecco's modified Eagle's medium, pH 9.0, which results in rapid dissociation of BB94 from the MT1-MMP at this high pH. Cells were scraped from the flasks and pelleted by centrifugation (1200 g). Lysates were prepared by resuspending cells in 5 mM Tris/HCl (pH 7.6), 100 µM PMSF, 1 µg/ml pepstatin A and 1 µg/ml E-64 [trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane], and incubated on ice before homogenization through a narrowgauge needle (26 G). Membranes were isolated by the method described previously [36] .
RESULTS
TIMP-2 and TIMP-4 share some important features, such as the ability to form bimolecular complexes with proMMP-2 [13] , yet they show profound differences in their ability to facilitate proMMP-2 activation by MT1-MMP at the cell surface [14, 16] . In order to advance our knowledge of the domain and sequence requirements of TIMP-2 allowing activation of proMMP-2 by MT1-MMP we introduced domains and sequence motifs of TIMP-4 into TIMP-2 and determined their effect on bimolecular complex formation with proMMP-2, their ability to establish trimolecular complexes with proE 375 → A MMP-2 and catMT1-MMP and their ability to facilitate proMMP-2 activation by MT1-MMP in a TIMP-2 −/− cellular model system.
Bimolecular complex formation: domain requirements of proMMP-2 for TIMP-4
Initially we investigated whether TIMP-4 interacts with proMMP-2 in a similar way to TIMP-2 to establish the proMMP-2 domain requirements in this process. In an earlier study we found that TIMP-2 bound to proMMP-2 via the haemopexin domain and was a weaker inhibitor of MMP-3, due to a lack of Cdomain interactions [29] , even though these domains share 50 % homology. The same chimaeric proteins comprised of the N-and C-domains of MMP-2 and SL were used as in Butler et al. [29] ( Figure 2 , top panel) to identify the proMMP-2 sequences that TIMP-4 binds to. Purified wild-type proMMP-2 and chimaeric forms of proMMP-2 with the C-domain of SL were incubated with TIMP-4 and N-TIMP-4. The complexes were isolated by affinity chromatography using gelatin-Sepharose followed by analysis of components present using SDS/PAGE ( Figure 2 , bottom panel). The C-terminal deletion mutant of proMMP-2 (pro 418−631 MMP-2) did not bind to either N-TIMP-4 or wildtype TIMP-4 (results not shown), indicating that the C-terminal domain of the enzyme was essential for proenzyme binding. In contrast, wild-type proMMP-2 and proMMP-2-C-SLGLGL (proMMP-2 mutant encoding C-terminal domain residues 248-305 from SL and residues 475-631 from MMP-2) formed a complex with wild-type TIMP-4 ( Figure 2 , bottom panel), while proMMP-2-C-SL (proMMP-2 mutant encoding the C-terminal domain of SL residues 248-460) and proMMP-2-C-SLGLSL (proMMP-2 mutant encoding C-terminal domain residues 248-305 and 400-460 from SL and residues 475-567 from MMP-2) showed no binding. N-TIMP-4 did not bind to either wildtype proMMP-2 or any of the proMMP-2 mutants, thereby underlining the dependence of proenzyme complex formation on C-terminal inhibitor interactions (results not shown). The binding motif for TIMP-4 was therefore localized in blades 3 and 4 of the β-propeller of proMMP-2 complementary to the TIMP-2-binding site, shown previously to be essential for activation of proMMP-2 by MT1-MMP [29] . Since TIMP-4 does not potentiate proMMP-2 activation by MT1-MMP [37] these Cterminal domain interactions must be considerably weaker, which was confirmed by kinetic analysis of the association rate constant k on for active MMP-2, which was 1.6 × 10 6 M −1 s −1 , and thus 3.6 times lower than that for TIMP-2 (5.9 × 10 6 M −1 s −1 ). Our data are in a similar range to previously published data by Bigg et al. [14] . In order to establish that the TIMP mutants ( Figure 1 , top panel) had a correctly folded C-terminal domain we assessed their ability to establish bimolecular complexes with the inactive proMMP-2 mutant proE 375 → A MMP-2. All mutants were incubated with equimolar concentrations of proE 375 → A MMP-2 for 24 h at room temperature. The reaction mixtures were then applied to gelatin-Sepharose matrices and bound proteins were eluted with 10 % DMSO in buffer. The eluted proteins were analysed by Western blotting to determine which TIMPs were able to form a bimolecular complex with proE 375 → A MMP-2. With the (Table 2) . These experiments were designed to determine the effect of the inhibitor Cterminal domain on the association rate of enzyme inhibitor complex formation (k on ) and overall stability of the complexes (K i ). Additionally, the effect of bound proE 375 → A MMP-2 to TIMP-4 was assessed to establish whether C-terminally bound proE 375 → A MMP-2 would influence the k on and apparent K i with active catMT1-MMP.
The k on values for catMT1-MMP binding to TIMP-4 and the proE 375 → A MMP-2-TIMP-4 complex were found to be in the range of (1-4) × 10 5 M −1 · s −1 . Since the association rate for the proE 375 → A MMP-2-TIMP-4 complex, full-length TIMP-4 and N-TIMP-4 and catMT1-MMP were of the same order of magnitude we can conclude that the C-terminal domain plays no role in catMT1-MMP inhibitor association.
The apparent K i values for inhibition of catMT1-MMP with full-length TIMP-4 and proE 375 → A MMP-2-TIMP-4 complex were found to be in the range ≈ 2.6 to ≈ 3.2 pM. In contrast, the apparent K i value for N-TIMP-4 and catMT1-MMP was 834 pM, a 300-fold increase when compared with full-length TIMP-4 or the proE 375 → A MMP-2-TIMP-4 complex. The catMT1-MMP complex with N-TIMP-4 was less stable due to lack of C-terminal domain interactions. Thus our data show for the first time that the affinity for the interaction between catMT1-MMP and full-length TIMP-4 is dependent on C-domain interactions with the catalytic domain of a target MMP. This contrasts with TIMP-2 interactions with catMT1-MMP, where the C-domain of TIMP-2 appears to show negligible binding to the enzyme [29] . 3 and 6) .The cell-conditioned medium was analysed by gelatin zymography. Active MMP-2 is indicated on the right. mass 63 000 Da), active MT1-MMP (60 000 Da) and the inactive C-terminal domain fragment (44 000 Da) that is still associated with the membrane (Figure 3, top panel, lane 1) . Exogenous addition of either TIMP-4, the proE 375 → A MMP-2-TIMP-4 complex or TIMP-2 showed that fragmentation of MT1-MMP was strongly inhibited (Figure 3, top panel, lanes 3, 5  and 7) . We concluded that degradation of MT1-MMP to the inactive fragment is dependent on MT1-MMP activity and is therefore autoproteolytic, as this was efficiently inhibited by TIMP-2, TIMP-4 and the proE 375 → A MMP-2-TIMP-4 complex. Furthermore our cells did not produce detectable amounts of proMMP-2; however, we cannot exclude that other MMPs may contribute to MT1-MMP fragmentation. . Thus both approaches demonstrated that TIMP-4 was unable to potentiate proMMP-2 activation by MT1-MMP, which is in agreement with previously published work [14] . Thus this cellular model system allowed us to use our TIMP-4 mutants to analyse gain of activating function in the MT1-MMP-transfected TIMP-2 −/− cells.
The role of the N-and C-terminal domains of TIMP-2 in trimolecular complex formation with proE 375 → A MMP-2 and active catMT1-MMP
To be able to define the sequence requirements for TIMP-2-dependent activation of proMMP-2 by MT1-MMP, we introduced TIMP-2 domains and sequence motifs into the related inhibitor, TIMP-4 (see Figure 1 , top panel, for details) [15, 38] . Bimolecular complexes between wild-type TIMP-2, TIMP-4 and the chimaeric inhibitors N-TIMP-2:C-TIMP-4 and N-TIMP-4:C-TIMP-2 were generated by incubating the inhibitors with proE 375 → A MMP-2 and isolated following gelatin-Sepharose chromatography. These bimolecular complexes were then incubated with active catMT1-MMP for 24 h at room temperature to allow the formation of possible trimolecular complexes. The mixtures were applied to gelatin-Sepharose matrices and bound proteins were analysed by Western blotting for the presence of catMT1-MMP forming a complex with wild-type or mutant TIMPs and proE 375 → A MMP-2. As shown in Figure 4 Figure 4, top panel, lanes 3 and 4) , which indicated that the three C-terminal loops, derived from TIMP-2, contributed to some degree to trimolecular complex formation, but were not the sole determinants in this process. However, the tail mutant TIMP-4:TIMP-2 Y178−P184 (TIMP-4 with tail-sequence residues 178-184 from TIMP-2) was unable to support a trimolecular complex ( Figure 5 , top panel, lane 2) and confirmed our data using the taildeletion mutant 186−194 TIMP-2 that lacked the same sequence motif, 187 EFLDIEDP 194 . These results indicated that the last 10 amino acid residues in TIMP-2 are vital for stable trimolecular To define further the sequence requirements for proE 375 → A MMP-2-TIMP-2-catMT1-MMP trimolecular complex formation, the tail mutant TIMP-4:TIMP-2 E192−D193 (TIMP-4 with tailsequence residues 192-193 from TIMP-2) was generated and analysed. The data revealed that this mutant showed binding of both proE 375 → A MMP-2 and catMT1-MMP in a trimolecular complex with the inhibitor (Figure 5, top panel, lane 3) . Thus in conclusion our data show that two amino acid residues within the tail-sequence motif of TIMP-2 contribute considerably to its ability to support stable trimolecular complex formation with proE 375 → A MMP-2 and catMT1-MMP. proMMP-2 by MT1-MMP was correct. As shown in Figure 5 (middle panel), the tail-deletion mutant 186−194 TIMP-2 was unable to promote processing of proMMP-2 by MT1-MMPcontaining membranes, demonstrating loss of function.
To narrow down the sequence requirements further, we generated an additional full-length TIMP-2 mutant, designated IQ-TIMP-2 ( Figure 1, top panel) 
DISCUSSION
ProMMP-2 activation by cell-surface-associated MT1-MMP is dependent on the establishment of a 'receptor' comprised of MT1-MMP and TIMP-2, which allows binding of proMMP-2, via C-terminal domain interactions, to the inhibitor. Subsequent processing of proMMP-2 by an adjacent inhibitor-free MT1-MMP molecule proceeds by autoproteolytic conversion into active MMP-2 in vitro and in vivo [21, 22] . It was the purpose of this study to identify the TIMP-2 domains and sequence motifs that govern proMMP-2 binding and activation by MT1-MMP in a TIMP-2-free environment. This approach allowed us to define the domain and detailed sequence requirements for this unique activation mechanism at the molecular level.
For this purpose, we developed stable cell lines overexpressing MT1-MMP in TIMP-2 −/− cells and established an efficient refolding protocol to produce recombinant full-length TIMP-4 and TIMP-4 domain mutants. The full-length wild-type and mutant TIMP-4 proteins were shown to bind both wild-type proMMP-2 and proE 375 → A MMP-2 and inhibited catMT1-MMP, thereby indicating structural integrity of both N-and Cterminal domains.
Analysis of bimolecular complex formation with proMMP-2 C-terminal domain SL chimaeric mutants showed that only one mutant formed a proenzyme-TIMP-4 complex (proMMP-2-C-SLGLGL), while the other two mutants were inactive. Indeed we speculated from the detailed analyses of the C-terminal MMP-2-binding site for TIMP-2 [37] that the positively charged cluster (K 558 , K 610 , K 617 and R 561 ) on MMP-2 would also be important for bimolecular complex formation with TIMP-4. Subsequently our data confirmed that the binding site for TIMP-4 to proMMP-2 mapped to this positively charged cluster as it is localized in blades 3 and 4 of the haemopexin-like C-terminal domain of proMMP-2 that is present in proMMP-2-C-SLGLGL [24, 29] . This part of MMP-2 contains two hydrophobic pockets that make direct contact with the C-terminal domain of TIMP-2, which are additionally flanked by electrostatic interactions and hydrogen bonds [24] . The X-ray data of the TIMP-2-proMMP-2 complex confirmed that the K 620 and K 610 residues of proMMP-2 form a double positive cluster that interacts with Y 139 on TIMP-2, which had been identified earlier by mutagenesis to be important for the bimolecular complex formation [37] . From the crystal structural data of the TIMP-2-proMMP-2 complex we can deduce that the C-terminal interactions within a TIMP-4-proMMP-2 complex are considerably weaker [24] . This is due to the lack of the hydrogen bond between T 153 -Y 607 and the salt bridge of R 170 -L 616 , as these residues are L 154 and H 171 in TIMP-4. Furthermore, a reduction of hydrophobic interactions at the centre of the pocket is also obvious, since M 149 in TIMP-2 is replaced by T 150 , a more hydrophilic amino acid in TIMP-4. The X-ray structural analysis also revealed important interactions between the tail sequence of TIMP-2 and proMMP-2, which are mainly electrostatic in nature [24] . . Therefore a bimolecular complex between TIMP-4 and proMMP-2 would be considerably less stable than the corresponding TIMP-2-proMMP-2 complex since important amino acid residues at the interaction interface are not conserved across these TIMPs. This is in agreement with our data and was also shown by elegant displacement experiments by Bigg et al. [14] , where TIMP-2 displaced TIMP-4 from a proMMP-2-TIMP-4 complex.
Subsequent kinetic analysis of catMT1-MMP inhibition demonstrated that full-length TIMP-4 was strongly dependent on C-terminal domain interactions between the inhibitor and catMT1-MMP, with apparent K i values below ≈ 3-2 pM. These values can only be regarded as a rough estimate of the true value, due to the limitations of the assay sensitivity, which did not allow us to perform these experiments at enzyme concentrations at or below the K i [34] . These values are considerably lower than those published recently [14] and may reflect differences in the experimental set up, since our experiments were performed using longer pre-incubation periods prior to analysis at 25
• C. Additionally, our k on values reported here for the interaction between catMT1-MMP and TIMP-4 vary by an order of magnitude from the values published for a transmembrane deletion mutant of MT1-MMP [14] , which may reflect C-terminal domain interaction between the C-terminal domain of MT1-MMP and TIMP-4 or indeed species differences between murine TIMP-4 used here and human TIMP-4. Unexpectedly, the apparent K i for the proE 375 → A MMP-2-TIMP-4 complex was nearly identical with that of full-length TIMP-4. We had predicted that the apparent K i for the proE 375 → A MMP-2-TIMP-4 complex would considerably increase, due to steric hindrance from the bound proE 375 → A MMP-2. However, our experiments show that this was not the case within the experimental limits of our analysis. We concluded that proE 375 → A MMP-2 possibly dissociated from the C-terminal domain of TIMP-4 following docking of catMT1-MMP to the N-terminal domain of the inhibitor. This was confirmed by our analysis of trimolecular complex formation, which showed that TIMP-4 dissociated from proE 375 → A MMP-2 in the presence of catMT1-MMP. Our data predicted that wildtype TIMP-4 would be unable to support proMMP-2 binding to a putative 'MT1-MMP/TIMP-4 receptor' at the cell surface and that proMMP-2 activation would be impaired. This was confirmed here experimentally, using TIMP-2 −/− cells transfected with MT1-MMP, and by others [14, 16] .
Analysis of trimolecular complex formation between TIMP-4 mutants, proE 375 → A MMP-2 and catMT1-MMP provided an important insight into the domain and detailed sequence requirements of TIMP-2 as a determinant for proMMP-2 activation at the cell surface. This approach demonstrated that wild-type TIMP-4 was unable to support stable trimolecular complex formation with catMT1-MMP and proE 375 → A MMP-2. In contrast, the chimaeric inhibitors N-TIMP-4:C-TIMP-2, as well as the TIMP-4:TIMP-2 tail mutants TIMP-4:TIMP-2 [24] . From our analyses of the stability of trimolecular complexes between proE 375 → A MMP-2, the TIMP-4 mutants and catMT1-MMP we can conclude that the charged tail sequence of TIMP-2 (E 192 -D 193 ) contributes considerably to their stability. This has been confirmed by the identified interactions of the charged tail of TIMP-2 with proMMP-2, which are only partially conserved in TIMP-4 [24] . In detail the loss of E 192 and D 193 does result in an impairment of trimolecular complex formation. These residues were also identified by Kai et al. [39] as major contributors to the stability of the TIMP-2-proMMP-2 complex, using a C-terminal myoglobin-fusion-protein approach.
ProMMP-2 activation by MT1-MMP in TIMP-2 −/− cells demonstrated that the chimaeric inhibitor N-TIMP-4:C-TIMP-2 induced processing of proMMP-2 to the intermediate form, while N-TIMP-2:C-TIMP-4 and wild-type TIMP-4 were completely inactive. The processing to the intermediate form of proMMP-2 can occur in the absence of TIMP-2 when concanavalin A is used in experimental model systems to stabilize artificially high MT1-MMP levels at the cell surface [21, 22] . However, our cell system only showed conversion into the intermediate or indeed fully active form when the appropriate amounts of wild-type or TIMP mutants were present. Although TIMP-4 represents a potent MT1-MMP inhibitor showing an apparent K i value below 2 pM, we had problems demonstrating that this inhibitor bound to cell-surface-associated MT1-MMP using both immunocytochemistry and Western blot analysis of cell lysates in our TIMP-2 −/− -derived cellular model system and this may be due to the lack of high-affinity TIMP-4 antibodies. Our k on data for the association rate constant of complex formation between catMT1-MMP and TIMP-4 showed that is was an order of magnitude lower than TIMP-2, indicating that the N-terminal domain interactions between MT1-MMP and TIMP-4 are less favourable. However, our data contrast with those published by Bigg et al. [14] , which reported that the association rate constant was higher for TIMP-4 than TIMP-2 for the interaction with a transmembrane deletion mutant of MT1-MMP. We cannot, however, confirm these results as analysis of a transmembrane deletion mutant of MT1-MMP with our murine TIMP-4 preparations revealed identical results to those observed with catMT1-MMP (M. Rapti, R. Williamson, M. H. Lee, V. Knäuper and G. Murphy, unpublished work) and we therefore believe that the murine TIMP-4 association rate is an order of magnitude lower than that of human TIMP-2. This could be in part due to the difference in the AB loop structure of the two TIMPs, which we had identified earlier to be an important determinant of the MT1-MMP-TIMP-2 interaction [25] and the lack of Y 36 in TIMP-4. In contrast, N-TIMP-4:C-TIMP-2 was identified in cell lysates of MT1-MMP-transfected cells from the TIMP-2 −/− mouse, leading us to conclude that the C-terminal domain of TIMP-2 is playing an important role in cell-surface association of the inhibitor.
The importance of the TIMP-2 tail-sequence motifs in proMMP-2 activation by MT1-MMP was further underlined using the tail-deletion mutant 186−194 TIMP-2 since it was unable to promote proMMP-2 activation by MT1-MMP at the cell surface. The loss of three salt bridges across the proMMP-2-TIMP-2 interaction interface rendered the tail-deletion mutant 186−194 TIMP-2 inactive [24] . We demonstrated that two amino acid residues of the TIMP-2 tail sequence were important for this unique ability of TIMP-2 to mediate proMMP-2 activation by MT1-MMP at the cell surface, since the IQ-TIMP-2 mutant showed impaired activation capability. This mutant has only lost a single salt bridge (E 192 -K 566 ) at the proMMP-2-TIMP-2 interface, and this loss is sufficient to impair proMMP-2 activation at the cell surface considerably [24] . In conclusion, our data have therefore identified the charged amino acid residues E 192 -D 193 within the TIMP-2 tail sequence as a major determinant for the establishment of the MT1-MMP/TIMP-2 'receptor', which allows proMMP-2 activation at the cell surface by MT1-MMP.
It is clear that TIMP-2 has unique relationships with both MT1-MMP and proMMP-2, and these relationships have evolved to fulfil its unique role in the activation of the latter by the former at the cell surface. This mechanism is utilized by cancer cells, allowing focal degradation of the extracellular matrix surrounding the tumour, which may be regarded as a trigger event for cell protrusion, migration and invasion, ultimately resulting in the establishment of metastases in distant organs. The data presented within this report have identified important amino acid residues in TIMP-2 that facilitate the unique mechanism of proMMP-2 activation by MT1-MMP. They form the basis for engineering TIMP-2 mutants that will efficiently block MT1-MMP-driven activation of proMMP-2, and these inhibitors will represent important novel tools in gene-therapeutic approaches to suppress tumour invasion and metastases in the future.
We thank Peter Loader for technical assistance during the initiation of the project, and Dr Rosalind Hembry for the immunization of a sheep with N-TIMP-4 and help with confocal microscopy. This work was supported by grants from the British Heart Foundation, the Wellcome Trust, the Nuffield Foundation, the Arthritis Research Campaign and the Biotechnology and Biological Sciences Research Council.
